Health care service for leprosy patients in Sitanala Tangerang (A proposed Health care service for leprosy patients in Sitanala Tangerang (A proposed approach of comprehensive health care for Leprosy patient) approach of comprehensive health care for Leprosy patient) Authors Authors Yunia Irawati, Yeni Dwi Lestari, Anna Puspitasari Bani, Sri Linuwih Menaldi, Luh Karunia Wahyuni, and Dewinta Retno Kurniawardhani transmitted via droplets and through direct and frequent contact with M. leprae-infected skin. M. leprae multiplies slowly with an average incubation period of 5 years, although it has been reported that symptoms may develop within 1 year or as long as 20 years in some cases (WHO, 2018) . The factors that influence the spread of leprosy are the pathogenicity of M. leprae, modes of transmission, immunological status, individual genetics, and socioeconomic and environmental circumstances Fitness, Tosh & Hill 2002) . Due to the presence of human immunity, only a few people could be infected with leprosy bacteria after contact with leprosy patients. Physiological factors such as puberty, menopause, pregnancy, and factors of infection and malnutrition can improve the clinical changes in leprosy. Most of the people (95%) are immune to leprosy, and only a small proportion (5%) are infected. Of the 5% who are infected, about 70% can heal themselves and 30% manifest symptoms (Department of Health, 2012) .
Leprosy is primarily found in developing countries, especially in tropical and subtropical regions such as Asia, Africa, and Latin America, which is due to the limitation in providing adequate services in the fields of health and education, complicated by low levels of social and economic welfare in the community. Southeast Asia is a region comprising developing countries with the highest number of new leprosy cases in the world, the number being estimated at as many as 154,834 in 2014. Indonesia is one of the developing countries with the highest number of new cases of leprosy in Southeast Asia and the third in the world after India and Brazil (Hogeweg 2010; WHO 2016) . Till date, leprosy is a health problem in Indonesia, despite the declaration of leprosy elimination in 2000, and the situation of leprosy is relatively static in Indonesia (Ministry of Health 2016).
The number of leprosy cases reported from countries of all the WHO regions was estimated at 176,176 at the end of 2015, or 0.18 cases per 10,000 population, with 211,973 new cases or 0.21 cases per 10,000 population (WHO, 2016) , whereas at the end of 2016, there were 173,358 cases with a prevalence rate corresponding to 0.29 cases per 10,000 population, and 216,108 new leprosy cases were reported from six WHO regions (WHO, 2018) . In 2016, the Indonesian Ministry of Health announced that there were 16,826 new cases of leprosy (6.5/100,000 inhabitants), with 84.19% of cases harboring the multibacillary (MB) type. According to gender, 62.47% of new leprosy patients were males and 37.53% of them were females. Most of the provinces in Indonesia have achieved elimination, whereas 11 provinces remain endemic, including East Java, North Sulawesi, Gorontalo, Central Sulawesi, West Sulawesi, Southeast Sulawesi, South Sulawesi, Maluku, North Maluku, Papua, and West Papua (Ministry of Health, 2017) .
Leprosy settlements in Indonesia comprise villages where leprosy patients who are either currently receiving or have completed the series of medication stay and live. One of these settlements is Sitanala located in Neglasari District, Tangerang City. It is named as Sitanala due to its proximity to the Sitanala Hospital, a leprosy-specific hospital established in 1956. This village built around 1980 was intended to temporarily accommodate leprosy patients being treated at Sitanala Hospital from all provinces in Indonesia who did not want to return to their original homes due to the negative stigma they received from their families or people around them, until they can build their own houses. Over time, this settlement became congested and more than half of the population are now ex-leprosy patients. These people are staying and living until now in this settlement (RSK Sitanala, 2018) .
According to the WHO leprosy classification, leprosy is classified into two types, paucibacillary (PB) and MB. The PB type has few lesions appearing on the skin (1-5 lesions), with asymmetrical distribution and showing negative result to bacteriological tests, whereas the MB type has more than five lesions, with symmetrical distribution and showing positive result to bacteriological tests . Leprosy patients generally have lesions around the face and tend to suffer from hand and foot disabilities.
Initially, the signs and symptoms of people infected with leprosy bacteria involve primarily the skin, nerves, and mucous membranes. The major symptoms of leprosy include skin lesions with decreased sensation (touch, temperature, or pain) and muscle weakness. If left untreated, it causes signs of advanced leprosy such as shortening of toes and fingers caused by reabsorption, paralysis, crippling of extremities, loss of eyebrows, and blindness (Courtright et al. 2002) .
Leprosy is also associated with the highest frequency of ocular complications (Rathinam 2010) , which can be sight-threatening, causing severe visual impairments that can lead to blindness. Furthermore, blindness can be influenced by several factors, especially steroid treatment in leprosy reactions, the leprosy type, duration of illness, late management of eye disorders, and social barriers due to patient ignorance or health workers that limit access to eye disorders (Hogeweg, 2010) . The presence of blindness along with another form of deformity will significantly reduce the quality of life of these leprosy patients and lead to a condition known as "double handicap."
Leprosy is treatable with multidrug therapy (MDT), which consists of a three-drug regimen, including rifampicin, dapsone, and clofazimine, with a duration of treatment between 6 months for the PB type and 12 months for the MB type. For adults and children aged >2 years who are in regular contact with leprosy patients, a single-dose rifampicin regimen is recommended as stated in the guidelines (WHO, 2018) . To stop the transmission of leprosy, complete multidrug regimen therapy and BCG vaccination is strongly recommended. The goals of MDT are breaking the chain of transmission, preventing drug resistance, shortening the treatment period, increasing the treatment compliance, preventing the occurrence of deformities, and averting the deterioration of deformities existing prior to treatment (Department of Health 2012).
Most of the leprosy patients have low education and low socioeconomic status that
render them more vulnerable and increase the risk of double handicaps. Limited access and cost of treatment to tertiary health services are also obstacles that delay these leprosy patients to admit themselves only when they have experienced vision-threatening complications. This delay carries the consequence of finding more patients with complex disabilities. There is practically no information regarding the condition of patients in this chronic state or after release from treatment, thus necessitating a system that can help address these problems. Furthermore, the negative stigma arising from the environment make people affected with leprosy unwilling to seek medical help. Most of the people surrounding leprosy patients are not aware of the cause of leprosy. Most of them assume that the causes of leprosy are curse, bad blood, heredity, punishment for sins, and eating certain types of food (Tabah et al, 2018; Naaz et al 2017) . A study conducted in Indonesia in 2017 by Susanto et al. found that self-care groups can increase the adherence of leprosy patients to completing the medication program. Motivation, guidance, and continuous support for leprosy patients are highly required to provide both positive effect on selfacceptance and constructive effect in accepting people with the disease (Susanto 2017) .
It is expected that this health service can be sustainable, can help detect early abnormalities caused due to leprosy, help provide treatment for ex-leprosy patients who already have disabilities, and provide knowledge about leprosy to former sufferers and local cadres for the continuity of health education. The purposes of this program are to determine the number of disabilities experienced by ex-leprosy patients, provide health care services such as conducting examinations and provision of free medication and eye glasses, and share knowledge to patients and local cadres.
Methods
Our social health care service program was conducted by a team of doctors from three departments, namely Ophthalmology, Dermatovenereology, and Medical Rehabilitation, from Cipto Mangunkusumo Hospital/Universitas Indonesia, Jakarta, at a leprosy settlement village in Tangerang City. The program was conducted in April 2018 for 2 days, with four primary activities involving promotive, preventive, curative, and rehabilitative program.
This program was led by an ophthalmologist team that invited members from other departments of Dermatolovenereology and Medical Rehabilitation. We collaborated and coordinated to strengthen the concept of this program. We planned for the schedule, prepared the examination flowchart and examination forms, and surveyed the location.
We met the director and the board of Sitanala Hospital to present this proposed program and to gather information about leprosy around the hospital. Coordination with the staff from Sitanala Hospital and local community leaders was made to help the team gather the participants. Two weeks before the program, we collected the data of ex-leprosy patients and then informed them about the program. The location selected was Sitanala Hospital Sport Hall, which is near and accessible from their houses. Cadres were contacted from the Head of Neglasari primary health care and were invited to the program. Leprosy cannot be spread via casual touch, for example, shaking hands, playing, or working together, (4) Leprosy generally starts with a patch finding on the skin with loss of touch and pain sensation; the patch can occur anywhere on the entire body, and (5) Complete MDT regimen can prevent permanent deformities and can stop transmission to other people.
We invited seven cadres from Neglasari District, known as WASOR (Vice Supervisor)
Cadre, to attend an in-depth discussion guided by specialists on the second day of the program. This discussion was aimed at imparting leprosy knowledge and sharing experience when facing leprosy patients ( Figure 3B ). The specialists provided information about wound-care management for leprosy patients, extremity exercises with ball-squeeze movement to prevent further contracture in patients who have had deformities, and steps to motivate and bring people suspected with leprosy and leprosy patients to see a doctor regularly. 
Eye Abnormalities
For the visual acuity examination, we performed two examinations consisting of uncorrected visual acuity (UCVA) without the use of glasses or lenses and best corrected visual acuity (BCVA) using lenses. Then, we made four classifications based on the WHO Vision Impairment Classification as follows: mild or no visual impairment (visual acuity ≥6/18), moderate visual impairment (visual acuity <6/18 to ≥6/60), severe visual impairment (visual acuity <6/60 to ≥3/60), and blindness (visual acuity <3/60 to no light perception).
By categorizing patients based on UCVA, they were grouped as follows: 65% had mild or no visual impairment, 26.5% had moderate visual impairment, 2.7% had severe visual impairment, and 5.8% were blind (Table 2) . Among patients with distant correctable refractive error (n = 58), all (100%) received spectacles, and among patients in need of additive lenses (n = 106), all (100%) received additive lenses, with 52 in the form of bifocal glasses. After the prescription of spectacles, there was a change in the abovementioned proportions as follows: 78.4% had mild or no visual impairment, 15.3% had moderate visual impairment, 1.9% had severe visual impairment, and 4.2% were blind, indicating an overall increase of 13.4% of patients in the mild or no visual impairment group and a decrease in the moderate, severe, and blindness groups. Table 3 . The three most common ocular abnormalities found in the patients were madarosis, followed by cataract and corneal hypoesthesia. It must be noted with caution that all the ocular abnormalities might not be related per se to leprosy. The findings depicted in Table   3 were detected in this specific population in the settlement. However, when related to leprosy and the profound adnexal involvement and its complications, entropion (15.9%), lagophthalmos (15.1%), and trichiasis (17.8%) should raise our concern, in terms of both number and clinical significance. All these abnormalities, along with corneal hypoesthesia, increase the risk of sight-threatening conditions. (Grzybowsi et al. 2015; Ebenezer et al. 2016; Lewallen et al. 2012) .
Patients with eye complications must be given treatment and intervention immediately to reduce the risk of further worsening or progression into blindness.
During the program, the team of doctors also gave artificial eye drops to help reduce the effects of dry eyes and prescribed antibiotic drops if there were signs of eye infection ( Figure 4 ). In this study, cataract, trichiasis, entropion, and lagophthalmos should and can be improved with an operative approach, and leg prosthesis can improve functioning of extremities. It has been documented that 42 lower extremities could be aided by prosthetics. Several patients (n = 26) have already been using prosthetics that are now unfortunately in a poor condition.
Fig. 4 Distribution of eyeglasses and medication

Severity of Leprosy
Of the total 260 subjects, 253 had complete data regarding the severity of leprosy; the data of 7 subjects were not available. The proportions of disabilities were as follows: 92% (foot), 87.7% (hand), and 52.5% (eye) ( Table 4 ). When combining the upper and lower extremities, the overall disabilities were anesthesia of a part of the hand or leg, muscle paralysis, ulcus, clawing, stiffness, drop hand, drop wrist, drop foot, and absorption. In this program, a moisturizer cream was given to moisten the skin and to prevent further ulcus caused by dryness of the skin and bacteria due to their low hygiene. As shown in Table 4 , the patients primarily had multiple disabilities, where one disability might lead to another, or worsen each other, increasing the overall morbidity.
In addition, although three departments have participated, considering the disabilities involved, it is suggested that in the future collaboration with the departments of Psychiatry and Orthopaedics could contribute to an even larger benefit.
Conclusion
A proposed model for the leprosy health care program with multi-department collaboration is highly effective in detecting multiple disabilities of leprosy patients at one time and in increasing the awareness of this neglected transmissible disease to patients and community. The coordination and collaboration with hospital staff and local community leaders were highly efficient in the collection of many ex-leprosy patients in the village for this proposed program.
